165 related articles for article (PubMed ID: 30142312)
21. Lipoid pneumonia as a complication of Lorenzo's oil therapy in a patient with adrenoleukodystrophy.
Majori M; Scarascia A; Anghinolfi M; Pisi R; Gnetti L; Casalini AG
J Bronchology Interv Pulmonol; 2014 Jul; 21(3):271-3. PubMed ID: 24992138
[TBL] [Abstract][Full Text] [Related]
22. A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.
Aubourg P; Adamsbaum C; Lavallard-Rousseau MC; Rocchiccioli F; Cartier N; Jambaqué I; Jakobezak C; Lemaitre A; Boureau F; Wolf C
N Engl J Med; 1993 Sep; 329(11):745-52. PubMed ID: 8350883
[TBL] [Abstract][Full Text] [Related]
23. Effect of dietary Lorenzo's oil and docosahexaenoic acid treatment for Zellweger syndrome.
Arai Y; Kitamura Y; Hayashi M; Oshida K; Shimizu T; Yamashiro Y
Congenit Anom (Kyoto); 2008 Dec; 48(4):180-2. PubMed ID: 18983586
[TBL] [Abstract][Full Text] [Related]
24. Medroxyprogesterone effects on colony growth, autophagy and mitochondria of C6 glioma cells are augmented with tibolone and temozolomide: Cell kinetic and electron microscopical studies with a broad review of the literature.
Elmaci İ; Ozpinar A; Bilir A; Altinoz MA
Clin Neurol Neurosurg; 2019 Feb; 177():77-85. PubMed ID: 30622045
[TBL] [Abstract][Full Text] [Related]
25. [Adrenoleukodystrophy: Lorenzo's Oil].
Yamawaki T
Brain Nerve; 2022 Dec; 74(12):1354-1357. PubMed ID: 36503132
[TBL] [Abstract][Full Text] [Related]
26. The influence of the penetrating peptide iRGD on the effect of paclitaxel-loaded MT1-AF7p-conjugated nanoparticles on glioma cells.
Gu G; Gao X; Hu Q; Kang T; Liu Z; Jiang M; Miao D; Song Q; Yao L; Tu Y; Pang Z; Chen H; Jiang X; Chen J
Biomaterials; 2013 Jul; 34(21):5138-48. PubMed ID: 23582684
[TBL] [Abstract][Full Text] [Related]
27. Reduction of CD200 expression in glioma cells enhances microglia activation and tumor growth.
Wang CY; Hsieh YT; Fang KM; Yang CS; Tzeng SF
J Neurosci Res; 2016 Dec; 94(12):1460-1471. PubMed ID: 27629530
[TBL] [Abstract][Full Text] [Related]
28. Morphological and histological changes of glioma cells immediately after 5-aminolevulinic acid mediated photodynamic therapy.
Kamoshima Y; Terasaka S; Kuroda S; Iwasaki Y
Neurol Res; 2011 Sep; 33(7):739-46. PubMed ID: 21756554
[TBL] [Abstract][Full Text] [Related]
29. Docosahexaenoic Acid Attenuates Doxorubicin-induced Cytotoxicity and Inflammation by Suppressing NF-κB/iNOS/NO Signaling Pathway Activation in H9C2 Cardiac Cells.
Wang ZQ; Chen MT; Zhang R; Zhang Y; Li W; Li YG
J Cardiovasc Pharmacol; 2016 Apr; 67(4):283-9. PubMed ID: 26657886
[TBL] [Abstract][Full Text] [Related]
30. Positive effects with Lorenzo's oil.
Siva N
Lancet Neurol; 2005 Sep; 4(9):529. PubMed ID: 16136703
[No Abstract] [Full Text] [Related]
31. Adrenoleukodystrophy and the mitochondrial connection: clues for supplementing Lorenzo's oil.
Moraes CT
Brain; 2013 Aug; 136(Pt 8):2339-41. PubMed ID: 23842565
[No Abstract] [Full Text] [Related]
32. More on Lorenzo's oil.
Odone A; Odone M
N Engl J Med; 1994 Jun; 330(26):1904-5. PubMed ID: 8196741
[No Abstract] [Full Text] [Related]
33. Dietary treatment for X-linked adrenoleukodystrophy: is "Lorenzo's oil" useful?
Prieto Tenreiro A; Penacho Lázaro MÁ; Andrés Celda R; Fernández Fernández M; González Mateo C; Díez Hernández A
Endocrinol Nutr; 2013 Jan; 60(1):37-9. PubMed ID: 22622158
[No Abstract] [Full Text] [Related]
34. Lorenzo's oil may help to prevent ALD symptoms.
Senior K
Lancet Neurol; 2002 Dec; 1(8):468. PubMed ID: 12849323
[No Abstract] [Full Text] [Related]
35. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
Abd El-Gawad HM; El-Sawalhi MM
J Biochem Mol Toxicol; 2004; 18(2):69-77. PubMed ID: 15122648
[TBL] [Abstract][Full Text] [Related]
36. Lorenzo's oil: advances in the treatment of neurometabolic disorders.
Ferri R; Chance PF
Arch Neurol; 2005 Jul; 62(7):1045-6. PubMed ID: 16009756
[No Abstract] [Full Text] [Related]
37. Lorenzo's oil: a reassessment.
Poulos A; Robertson EF
Med J Aust; 1994 Mar; 160(6):315-7. PubMed ID: 8133809
[No Abstract] [Full Text] [Related]
38. Adrenoleukodystrophy: magnetic resonance follow-up after Lorenzo's oil therapy.
Duchesne N; Dufour M; Bouchard G; Grondin P; Lemieux B
Can Assoc Radiol J; 1995 Oct; 46(5):386-91. PubMed ID: 7552831
[TBL] [Abstract][Full Text] [Related]
39. Lorenzo's oil and thrombocytopenia in patients with adrenoleukodystrophy.
Zinkham WH; Kickler T; Borel J; Moser HW
N Engl J Med; 1993 Apr; 328(15):1126-7. PubMed ID: 8455677
[No Abstract] [Full Text] [Related]
40. Study and evaluation of nucleolin-targeted delivery of magnetic PLGA-PEG nanospheres loaded with doxorubicin to C6 glioma cells compared with low nucleolin-expressing L929 cells.
Mosafer J; Teymouri M; Abnous K; Tafaghodi M; Ramezani M
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():123-133. PubMed ID: 28024568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]